{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:03:56Z","timestamp":1789941836990,"version":"4.0.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002559","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T22:35:10Z","timestamp":1384468510000},"page":"e2559","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Resistance of M. leprae to Quinolones: A Question of Relativity?"],"prefix":"10.1371","volume":"7","author":[{"given":"Nicolas","family":"Veziris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Chauffour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Escolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Henquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jarlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"DM Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref2","first-page":"317","article-title":"Global leprosy situation, 2012","volume":"87","year":"2012","journal-title":"WHO"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.47276\/lr.78.4.330","article-title":"The impact of leprosy control on the transmission of <italic>M. leprae<\/italic>: is elimination being attained?","volume":"78","author":"JH Richardus","year":"2007","journal-title":"Lepr Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jinf.2004.03.012","article-title":"Mutations in genes related to drug resistance in <italic>Mycobacterium leprae<\/italic> isolates from leprosy patients in Korea","volume":"50","author":"E-Y You","year":"2005","journal-title":"J Infect"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.47276\/lr.78.4.343","article-title":"The frequency of drug resistance mutations in <italic>Mycobacterium leprae<\/italic> isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines","volume":"78","author":"M Matsuoka","year":"2007","journal-title":"Lepr Rev"},{"key":"ref6","first-page":"672","article-title":"Primary and secondary dapsone resistance of <italic>M. leprae<\/italic> in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985","volume":"55","author":"CC Guelpa-Lauras","year":"1987","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref7","first-page":"263","article-title":"Primary dapsone resistance in China","volume":"60","author":"JK Chen","year":"1989","journal-title":"Lepr Rev"},{"key":"ref8","first-page":"607","article-title":"Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin","volume":"57","author":"JH Grosset","year":"1989","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref9","first-page":"S81","article-title":"Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy","volume":"71 Suppl","author":"B Ji","year":"2000","journal-title":"Lepr Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/324623","article-title":"Molecular Detection of Rifampin and Ofloxacin Resistance for Patients Who Experience Relapse of Multibacillary Leprosy","volume":"34","author":"E Cambau","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1128\/AAC.01162-07","article-title":"Powerful bactericidal activity of moxifloxacin in human leprosy","volume":"52","author":"FEF Pardillo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(05)60888-4","article-title":"Multidrug-resistance to dapsone, rifampicin, and ofloxacin in <italic>Mycobacterium leprae<\/italic>","volume":"349","author":"E Cambau","year":"1997","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/AAC.45.12.3635-3639.2001","article-title":"Multidrug Resistant <italic>Mycobacterium leprae<\/italic> from Patients with Leprosy","volume":"45","author":"S Maeda","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0928-8244(03)00038-5","article-title":"Detection of gene mutations related with drug resistance in <italic>Mycobacterium leprae<\/italic> from leprosy patients using Touch-Down (TD) PCR","volume":"36","author":"S-K Kim","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.01095-07","article-title":"Are All the DNA Gyrase Mutations Found in <italic>Mycobacterium leprae<\/italic> Clinical Strains Involved in Resistance to Fluoroquinolones?","volume":"52","author":"S Matrat","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1838","DOI":"10.1371\/journal.pntd.0001838","article-title":"Impact of amino acid substitutions in B subunit of DNA gyrase in <italic>Mycobacterium leprae<\/italic> on fluoroquinolone resistance","volume":"6","author":"K Yokoyama","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.05890-11","article-title":"Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to <italic>Mycobacterium leprae<\/italic>","volume":"56","author":"K Yokoyama","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1489\/1544-581X(2003)71<240:ASCOMM>2.0.CO;2","article-title":"A Second Case of Multidrug-resistant <italic>Mycobacterium leprae<\/italic> Isolated from a Japanese Patient with Relapsed Lepromatous Leprosy","volume":"71","author":"M Matsuoka","year":"2003","journal-title":"International Journal of Leprosy and Other Mycobacterial Diseases"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.06561-11","article-title":"Drug and multidrug resistance among <italic>Mycobacterium leprae<\/italic> isolates from Brazilian relapsed leprosy patients","volume":"50","author":"A Da Silva Rocha","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref20","first-page":"7","article-title":"The \u201cproportional bactericidal test\u201d: a method for assessing bactericidal activity in drugs against <italic>Mycobacterium leprae<\/italic> in mice","volume":"49","author":"MJ Colston","year":"1978","journal-title":"Lepr Rev"},{"key":"ref21","first-page":"78","article-title":"A method for counting acid-fast bacteria","volume":"36","author":"CC Shepard","year":"1968","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref22","first-page":"96","article-title":"Statistical analysis of results obtained by two methods for testing drug activity against <italic>Mycobacterium leprae<\/italic>","volume":"50","author":"CC Shepard","year":"1982","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1574-6968.1989.tb03678.x","article-title":"A rapid method for the detection of potentially viable <italic>Mycobacterium leprae<\/italic> in human biopsies: a novel application of PCR","volume":"53","author":"SA Woods","year":"1989","journal-title":"FEMS Microbiol Lett"},{"key":"ref24","first-page":"452","article-title":"A <italic>Mycobacterium leprae<\/italic> isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin","volume":"68","author":"M Matsuoka","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/AAC.44.10.2919-2921.2000","article-title":"Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against <italic>Mycobacterium leprae<\/italic> in mice","volume":"44","author":"S Consigny","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.50.4.1558-1560.2006","article-title":"Bactericidal activities of R207910 and other newer antimicrobial agents against <italic>Mycobacterium leprae<\/italic> in mice","volume":"50","author":"B Ji","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.01282-06","article-title":"Expression and purification of an active form of the <italic>Mycobacterium leprae<\/italic> DNA gyrase and its inhibition by quinolones","volume":"51","author":"S Matrat","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/AAC.48.3.765-773.2004","article-title":"Activities of garenoxacin against quinolone-resistant <italic>Streptococcus pneumoniae<\/italic> strains in vitro and in a mouse pneumonia model","volume":"48","author":"E Azoulay-Dupuis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/AAC.00176-09","article-title":"In vitro activity of garenoxacin against <italic>Streptococcus pneumoniae<\/italic> mutants with characterized resistance mechanisms","volume":"53","author":"K Yamamoto","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/AAC.00049-09","article-title":"Sitafloxacin and garenoxacin may overcome the antibiotic resistance of <italic>Helicobacter pylori<\/italic> with <italic>gyrA<\/italic> mutation","volume":"53","author":"H Suzuki","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijantimicag.2011.09.021","article-title":"In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant <italic>Streptococcus pneumoniae<\/italic>","volume":"39","author":"Y Fukuda","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5025\/hansen.76.11","article-title":"[In-vitro and in-vivo activities of moxifloxacin and garenoxacin against <italic>Mycobacterium leprae<\/italic>]","volume":"76","author":"M Gidoh","year":"2007","journal-title":"Nihon Hansenbyo Gakkai Zasshi"},{"key":"ref33","unstructured":"European Medicines Agency (2007) Questions and answers on the withdrawal of the marketing application for Garenoxain Mesylate. London: European Medicines Agency."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1128\/AAC.00968-10","article-title":"Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model","volume":"54","author":"J Poissy","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/AAC.00944-06","article-title":"Functional Analysis of DNA Gyrase Mutant Enzymes Carrying Mutations at Position 88 in the A Subunit Found in Clinical Strains of <italic>Mycobacterium tuberculosis<\/italic> Resistant to Fluoroquinolones","volume":"50","author":"S Matrat","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/AAC.40.2.393","article-title":"Bactericidal activities of combinations of new drugs against <italic>Mycobacterium leprae<\/italic> in nude mice","volume":"40","author":"B Ji","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.40.9.2137","article-title":"Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against <italic>Mycobacterium leprae<\/italic> in patients","volume":"40","author":"B Ji","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5588\/09640569513011","article-title":"Ofloxacin population pharmacokinetics in patients with tuberculosis","volume":"6","author":"JJ Stambaugh","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref39","first-page":"259","article-title":"Activity of ofloxacin against <italic>Mycobacterium leprae<\/italic> in the mouse","volume":"56","author":"JH Grosset","year":"1988","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/AAC.44.10.2600-2603.2000","article-title":"Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers","volume":"44","author":"A Lubasch","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.47.12.3935-3941.2003","article-title":"Pharmacodynamics of the New Des-F(6)-Quinolone Garenoxacin in a Murine Thigh Infection Model","volume":"47","author":"D Andes","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1128\/AAC.47.7.2256-2263.2003","article-title":"Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects","volume":"47","author":"DA Gajjar","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0195-6701(91)90215-T","article-title":"The pharmacokinetics of clarithromycin and its 14-OH metabolite","volume":"19","author":"PG Davey","year":"1991","journal-title":"Journal of Hospital Infection"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/AAC.46.5.1425-1434.2002","article-title":"Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia","volume":"46","author":"PR Tessier","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1371\/journal.pntd.0001739","article-title":"Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test","volume":"6","author":"E Cambau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7883\/yoken.63.412","article-title":"Possible Mode of Emergence for Drug-Resistant Leprosy Is Revealed by an Analysis of Samples from Mexico","volume":"63","author":"M Matsuoka","year":"2010","journal-title":"Jpn J Infect Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T14:40:18Z","timestamp":1688654418000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002559"}},"subtitle":[],"editor":[{"given":"Gerd","family":"Pluschke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002559","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}